About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
ESMO Breast Cancer 2023 Congress Coverage
Videos
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
M
ESMO Breast Cancer 2023 Results of Part B of SOLTI TOT-HER3 Window of Opportunity Trial: Patritumab Deruxtecan in HR+/HER2- & TNBC
By
ESMO Breast Cancer 2023 Congress Coverage
FEATURING
Mafalda Oliveira
By
ESMO Breast Cancer 2023 Congress Coverage
FEATURING
Mafalda Oliveira
297 views
May 31, 2023
0 Comments
Login to view comments.
Click here to Login
Videos
19:34
ESMO Breast Cancer 2023 Congress Coverage
ESMO Breast Cancer 2023 Clinical Impact of Evolving ADC Technology
Feat.
H. McArthur
10:48
ESMO Breast Cancer 2023 Congress Coverage
ESMO Breast Cancer 2023 Results of Part B of SOLTI TOT-HER3 Window o…
Feat.
M. Oliveira
16:20
ESMO Breast Cancer 2023 Congress Coverage
ESMO Breast Cancer 2023: Role of Germline Genetic Testing in Early B…
Feat.
S. Lee
07:49
ESMO Breast Cancer 2023 Congress Coverage
ESMO Breast Cancer 2023 KEYNOTE-355 Trial: Outcomes in TNBC Patients…
Feat.
H. Rugo
17:44
ESMO Breast Cancer 2023 Congress Coverage
ESMO Breast Cancer 2023 Phase 3 DESTINY-Breast04 Trial Safety Analys…
Feat.
H. Rugo
14:38
ESMO Breast Cancer 2023 Congress Coverage
ESMO Breast Cancer 2023 Phase 3b LUCY Trial Subgroup Analysis: Clini…
Feat.
K. Gelmon
17:03
ESMO Breast Cancer 2023 Congress Coverage
ESMO Breast Cancer 2023 Clinical Implementation of Oral SERD: Presen…
Feat.
C. Criscitiello
10:06
ESMO Breast Cancer 2023 Congress Coverage
ESMO Breast Cancer 2023 DORA Phase 2 Study: Durvalumab and Olaparib …
Feat.
T. Tan
14:11
ESMO Breast Cancer 2023 Congress Coverage
ESMO Breast Cancer 2023 Highlights: Key Studies Including IMPassion0…
Feat.
P. Tarantino
16:58
ESMO Breast Cancer 2023 Congress Coverage
ESMO Breast Cancer 2023: Who Really Benefits From IO? Can We Identif…
Feat.
J. Balko
09:56
ESMO Breast Cancer 2023 Congress Coverage
ESMO Breast Cancer 2023 EMERALD Trial: Analysis of PROs in Patients …
Feat.
J. Cortes
05:47
ESMO Breast Cancer 2023 Congress Coverage
ESMO Breast Cancer 2023 DATA Trial Analysis: The Prognostic and Pred…
Feat.
S. Lammers
